Edwards Lifesciences tells Reuters the company is cooperating with EU antitrust regulators after a raid that took place last week. Edwards tells Reuters it is “committed to healthy, fair competition” and “remains confident in its business practices,” the news service noted.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on EW:
- Edwards Lifesciences (EW) Under the Radar of EU Antitrust Regulators
- DraftKings upgraded, Snap initiated at Sell: Wall Street’s top analyst calls
- Early notable gainers among liquid option names on September 26th
- Edwards Lifesciences targeted in EU antitrust raid, Reuters reports
- Oppenheimer upgrades Edwards Lifesciences, says GLP-1 fears misplaced